Syndrome de Lyell chez trois malades VIH (+) sous traitement antituberculeux

[1]  A. Zigani,et al.  Effets secondaires des antituberculeux : place du bilan préthérapeutique dans les pays en développement (P.E.D.) , 2008 .

[2]  L. Boussoffara,et al.  Les effets indésirables cutanés des antituberculeux , 2006 .

[3]  P. Pitché,et al.  Syndromes de Stevens-Johnson et de lyell après la prise de rifampicine-isoniazide chez 8 malades infectés par le vih au Togo , 2005 .

[4]  B. Kouassi,et al.  Epidémiologie de la tuberculose à Abidjan, Côte d'Ivoire évolution sous la poussée de l'infection a VIH , 1999 .

[5]  R. Bercion,et al.  HIV seroprevalence rate and incidence of adverse skin reactions in adults with pulmonary tuberculosis receiving thiacetazone free anti-tuberculosis treatment in Yaounde, Cameroon. , 1997, East African medical journal.

[6]  Theresa Anderson,et al.  Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis , 1995 .

[7]  R. Stern,et al.  Severe adverse cutaneous reactions to drugs. , 1994, The New England journal of medicine.

[8]  Alimuddin Zumla,et al.  Cutaneous hypersensitivity reactions due to thiacetazone in the treatment of tuberculosis in Zambian children infected with HIV-I. , 1993, Archives of disease in childhood.

[9]  S. Lucas,et al.  Cutaneous hypersensitivity reactions due to thiacetazone in HIV-1 seropositive patients treated for tuberculosis , 1991, The Lancet.

[10]  F. Simonnet,et al.  Lyell's syndrome associated with rifampicin therapy of tuberculosis in an AIDS patient. , 1990, Scandinavian journal of infectious diseases.

[11]  Y. Kitano,et al.  Toxic epidermal necrolysis due to rifampicin. , 1987, Journal of the American Academy of Dermatology.